A Review of Recent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitor Research Activity

Author(s): Jeffrey W. Corbett .

Journal Name: Current Medicinal Chemistry - Anti-Infective Agents

Volume 1 , Issue 2 , 2002


This non-nucleoside reverse transcriptase inhibitor review covers the patent and published literature from January, 1998-August, 2001. Major advances have been made in the past decade in discovering non-nucleoside reverse transcriptase inhibitors that are effective in inhibiting replication of wild-type virus. Attention is now focused upon the discovery of agents that are effective in inhibiting replication of virus with singly and doubly mutated HIV-1 reverse transcriptase. Notable advances in the discovery of such broad spectrum therapeutics are SG-153 and the quinazolines DPC961 and DPC083. Attempts at discovering other broad spectrum anti-viral agents are presented herein.

Keywords: Hiv-1 non-nucleoside reverse transcriptase inhibitor, nnrti, stavudine

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2002
Page: [119 - 140]
Pages: 22
DOI: 10.2174/1568012023354938
Price: $58

Article Metrics

PDF: 1